Statististically significant decreases were noted in 2021, at 6.65/1,000 overall, and 2022, at 7.37/1,000 overall (each year p = 0.03 compared to 2018 dispensings), but failed to reach statistical significance in 2023, at 7.37/1,000 overall ( p = 0.18 vs. 2018).
← all excerpts
Changes in epinephrine dispensings and allergy hospitalisations in Sweden in the years following the removal of autoinjector co-payments.
1
0.1800
0.1800